Acute infections in children are accompanied by oxidative modification of LDL and decrease of HDL cholesterol, and

Petru Liuba1, Jerker Persson, Jukka Luoma

  • 1Division of Pediatric Cardiology, Department of Paediatrics, Lund University Hospital, Sweden. petru.liuba@pedi.lu.se

European Heart Journal
|March 20, 2003
PubMed

Insights

Acute infections in children can lead to changes in blood lipids and carotid artery thickening, suggesting a potential increased risk for atherosclerosis development early in life.

Area of Science:

  • Pediatric Cardiology
  • Vascular Biology
  • Infectious Diseases

Background:

  • Atherosclerosis, a disease of the arteries, has its origins in childhood.
  • The role of acute infections in the early development of atherosclerosis is not fully understood.

Purpose of the Study:

  • To investigate the impact of acute infections on carotid artery wall morphology and lipid profiles in children.
  • To explore the potential link between childhood infections and the early stages of atherosclerosis.

Main Methods:

  • Carotid intima-media thickness (IMT) was measured using high-resolution ultrasound in 28 children with acute infections and 20 healthy controls.
  • Analysis included antibodies against oxidized low-density lipoprotein (anti-oxLDL) and high-density lipoprotein cholesterol (HDL-C) levels.
  • Measurements were taken during acute illness and three months post-infection.

Main Results:

  • Children with acute infections showed increased anti-oxLDL antibodies and decreased HDL-C during illness compared to controls and post-infection.
  • A significant thickening of the carotid intima-media was observed three months after the acute infection.
  • Antibiotic treatment during acute illness was associated with less carotid thickening.

Conclusions:

  • Acute infections in children are linked to increased LDL oxidation and reduced HDL-C.
  • These lipid alterations may precede and contribute to carotid artery wall thickening.
  • Childhood acute infections might represent an early risk factor for atherosclerosis, necessitating further research.
Abstract

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...